|
시장보고서
상품코드
2051186
능동형 이식형 의료기기 시장 : 제품별, 최종사용자별, 지역별Active Implantable Medical Devices Market, By Product, By End Users, By Geography |
||||||
능동형 이식형 의료기기 시장은 2026년에 294억 9,000만 달러로 추정되고, 2033년까지 492억 5,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 7.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 294억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.60% | 2033년 시장 규모 예측 : | 492억 5,000만 달러 |
세계 능동형 이식형 의료기기 시장의 성장은 전 세계 고령화 및 만성질환 유병률 증가에 의해 주도되고 있습니다. 능동형 이식형 의료기기는 다양한 질환의 치료를 위해 인체 내에 이식되는 배터리 구동식 의료기기를 말합니다. 주요 능동형 이식형 의료기기에는 이식형 제세동기(ICD), 신경자극기, 이식형 약물 펌프 등이 있습니다. ICD는 빈맥, 심실세동과 같은 생명을 위협하는 심장질환 치료에 널리 사용되고 있습니다. 신경자극기는 만성통증 관리뿐만 아니라 간질, 파킨슨병 등 신경질환 관리에도 도움이 됩니다. 이식형 약물 펌프는 암, 관절염 등의 질환에 대해 국소 약물 전달을 효과적으로 할 수 있도록 도와줍니다. 지속적인 의료 발전과 소형화 및 첨단 기술을 갖춘 이식형 기기 개발에 대한 관심이 높아짐에 따라 예측 기간 동안 능동형 이식형 의료기기 시장의 성장을 견인할 것으로 예측됩니다.
시장 역학
만성질환에 취약한 고령 인구 증가, 최소침습수술에 대한 수요 증가, 심장질환 및 신경질환의 유병률 증가는 세계 능동형 이식형 의료기기 시장의 성장을 견인할 것으로 보입니다. 유엔에 따르면 60세 이상 인구는 현재 10억 명에서 2050년까지 전 세계적으로 21억 명에 달할 것으로 예측했습니다. 장기적인 효과와 원격 모니터링의 용이성 등의 장점으로 인해 기존 약물 치료나 의료기기보다 이식형 장치에 대한 선호도가 높아지면서 능동형 이식형 의료기기의 보급이 확대될 것으로 보입니다. 그러나 특히 개발도상국에서 고가의 임플란트 기기에 대한 보험 적용의 제한, 안전 문제로 인한 잦은 제품 리콜, 엄격한 규제 승인 등은 예측 기간 동안 시장 성장을 저해할 수 있습니다. 로봇공학, 바이오프린팅, 3D 프린팅, 장기 이식용 소형 배터리 구동 장치의 개발 등 지속적인 기술 혁신은 능동형 이식형 의료기기 시장 기업에게 성장 기회를 제공할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략)를 기반으로 세계 능동형 이식형 의료기기 시장의 주요 기업을 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계 액티브 임베디드 의료기기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 능동형 이식형 의료기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 능동형 이식형 의료기기 시장 : 제품별, 2021년-2033년
제5장 세계의 능동형 이식형 의료기기 시장 : 최종사용자별, 2021년-2033년
제6장 세계의 능동형 이식형 의료기기 시장 : 지역별, 2021년-2033년
제7장 경쟁 구도
제8장 애널리스트의 제안
제9장 조사 방법
LSH 26.06.17Active Implantable Medical Devices Market is estimated to be valued at USD 29.49 Bn in 2026 and is expected to reach USD 49.25 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 29.49 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.60% | 2033 Value Projection: | USD 49.25 Bn |
Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.
Market Dynamics
Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global active implantable medical devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics.
- Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global active implantable medical devices market.
Market Segmentation
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Implantable Cardioverter Defibrillators
- Implantable Cardiac Pacemakers
- Ventricular Assist Devices
- Implantable Heart Monitors/Insertable Loop Recorders
- Neurostimulators
- Implantable Hearing Devices
- Others
- End Users Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgery Center
- Specialty Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- Biotronik SE & Co. KG
- Cochlear Ltd.
- William Demant Holding A/S
- Sonova Holding AG
- MED-EL
- Nurotron Biotechnology Co. Ltd.
- Zimmer Biomet Holdings, Inc.
- Nevro Corp.
- Second Sight Medical Products, Inc.
- Nuvectra Corporation
- Aleva Neurotherapeutics SA
- Pixium Vision
- Retina Implant AG
- Corindus Vascular Robotics, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Active Implantable Medical Devices Market, By Product, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Implantable Cardioverter Defibrillators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Implantable Cardiac Pacemakers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ventricular Assist Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Implantable Heart Monitors/Insertable Loop Recorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurostimulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Implantable Hearing Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (fully-automatic vial-filling machine, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Active Implantable Medical Devices Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgery Center
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Active Implantable Medical Devices Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Company Profiles
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biotronik SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cochlear Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- William Demant Holding A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sonova Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MED-EL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nurotron Biotechnology Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zimmer Biomet Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nevro Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Second Sight Medical Products, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nuvectra Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aleva Neurotherapeutics SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pixium Vision
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Retina Implant AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Corindus Vascular Robotics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic plc
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. Research Methodology
- References
- Research Methodology
- About us and Sales Contact
